Clinical Trial Update: Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant celecoxib and capecitabine with pelvic irradiation in stage II/III rectal adenocarcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Celecoxib (Celebrex) (celecoxib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED